Theravance Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TBPH and other ETFs, options, and stocks.About TBPH
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments.
CEORick E. Winningham
CEORick E. Winningham
Employees97
Employees97
HeadquartersSouth San, California
HeadquartersSouth San, California
Founded2013
Founded2013
Employees97
Employees97
TBPH Key Statistics
Market cap749.88M
Market cap749.88M
Price-Earnings ratio63.92
Price-Earnings ratio63.92
Dividend yield—
Dividend yield—
Average volume363.17K
Average volume363.17K
High today$15.02
High today$15.02
Low today$14.58
Low today$14.58
Open price$14.89
Open price$14.89
Volume271.78K
Volume271.78K
52 Week high$15.34
52 Week high$15.34
52 Week low$7.90
52 Week low$7.90
Stock Snapshot
With a market cap of 749.88M, Theravance Biopharma(TBPH) trades at $14.58. The stock has a price-to-earnings ratio of 63.92.
As of 2025-11-06, Theravance Biopharma(TBPH) stock has fluctuated between $14.58 and $15.02. The current price stands at $14.58, placing the stock 0.0% above today's low and -2.9% off the high.
The Theravance Biopharma(TBPH)'s current trading volume is 271.78K, compared to an average daily volume of 363.17K.
During the past year, Theravance Biopharma(TBPH) stock moved between $7.90 at its lowest and $15.34 at its peak.
During the past year, Theravance Biopharma(TBPH) stock moved between $7.90 at its lowest and $15.34 at its peak.
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own TBPH. This list is generated using Robinhood data, and it’s not a recommendation.